# PDCD5

## Overview
Programmed Cell Death 5 (PDCD5) is a gene that encodes a protein involved in the regulation of apoptosis and cell cycle arrest. The PDCD5 protein is characterized by a complex structure, including a triple-helix bundle core and flexible terminal regions, which facilitate its interactions with other cellular components (Liu2004Human; Yao2009Structure–function). Functionally, PDCD5 plays a critical role in stabilizing the tumor suppressor protein p53, thereby influencing the p53 pathway and promoting apoptosis and cell cycle regulation (Xu2012PDCD5). It also interacts with other proteins such as TIP60, enhancing its activity in DNA repair and apoptosis (Xu2009PDCD5). Clinically, alterations in the PDCD5 gene have been associated with various cancers, including lung cancer and chronic myelogenous leukemia, highlighting its significance in cancer biology (Ma2005Two; Spinola2006Association).

## Structure
The human programmed cell death 5 (PDCD5) protein is characterized by a complex molecular structure that includes distinct regions and structural features. The primary structure of PDCD5 consists of a specific sequence of amino acids, with notable conservation across species (Liu2004Human). The secondary structure includes multiple alpha-helices, with the N-terminal region forming a stable α-helix independently of the core (Liu2005The). The core region of PDCD5 is a triple-helix bundle, consisting of helices a3 to a5, which is a key structural feature providing stability through hydrophobic and ionic interactions (Yao2009Structure–function).

The tertiary structure of PDCD5 is defined by its helical core and two dissociated terminal regions. The N-terminal region, although ordered, is not rigid and contains abundant secondary structure, while the C-terminal region is unstructured and mobile, potentially interacting with nucleic acids (Liu2004Human; Yao2009Structure–function). The protein's dynamic properties, including flexible and ordered regions, suggest roles in protein-nucleic acid interactions (Liu2004Human). PDCD5 does not have a quaternary structure involving multiple subunits, as indicated by the available data.

## Function
PDCD5 is a gene that encodes a protein involved in regulating apoptosis and cell cycle arrest in healthy human cells. The PDCD5 protein interacts with the p53 tumor suppressor pathway, playing a crucial role in stabilizing p53 levels by impairing Mdm2-mediated degradation, ubiquitination, and nuclear export of p53. This stabilization is essential for the regulation of the cell cycle and apoptosis, as p53 is a key regulator of these processes (Xu2012PDCD5).

PDCD5 also influences the expression and transcription of p21, a p53 target gene involved in cell cycle arrest. It associates with the p21 promoter, particularly at the p53 binding site, facilitating transcriptional activation after DNA damage (Xu2012PDCD5). In addition to its role in apoptosis, PDCD5 enhances the stability and activity of TIP60, a histone acetyltransferase involved in DNA repair and apoptosis, by promoting its acetyltransferase activity and protecting it from proteasomal degradation (Xu2009PDCD5).

PDCD5 is active in both the cytoplasm and nucleus, where it translocates during apoptosis to interact with several molecules, including TP53 and HDAC3, which are part of signaling networks often disrupted in cancer cells (Li2016Cellular).

## Clinical Significance
Alterations in the PDCD5 gene have been linked to various cancers, including lung cancer and chronic myelogenous leukemia (CML). In lung cancer, a single nucleotide polymorphism (SNP) rs1862214 located upstream of the PDCD5 gene is associated with an increased risk of developing the disease, particularly in smokers. Individuals with GG or CG genotypes for this SNP have a higher risk of lung cancer and poorer clinical outcomes, such as advanced disease stages and reduced survival rates (Spinola2006Association). 

In CML, two SNPs in the PDCD5 promoter region, À27A>G and À11G>A, are associated with reduced promoter activity and increased susceptibility to the disease. These SNPs are in complete linkage disequilibrium and result in lower PDCD5 expression, which may contribute to the progression of CML by affecting the gene's response to apoptotic stimuli (Ma2005Two).

PDCD5 also plays a role in the p53 pathway, where it stabilizes p53 by counteracting Mdm2-induced degradation. This interaction is crucial for maintaining p53 stability, which is essential for its function in the cellular response to DNA damage. Alterations in PDCD5 expression can impact p53-mediated transcription and cell cycle regulation, potentially influencing cancer progression (Xu2012PDCD5).

## Interactions
Programmed Cell Death Protein 5 (PDCD5) is involved in several protein interactions that influence its role in apoptosis and cellular stress responses. PDCD5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT), forming a stable complex that regulates β-tubulin folding. This interaction suggests a regulatory role for PDCD5, as it binds to the apical domain of the CCTβ subunit, potentially interfering with β-tubulin binding and folding (Tracy2014Programmed).

PDCD5 also interacts with the tumor suppressor protein p53, functioning as a positive regulator in the p53 pathway. It enhances p53 stability by protecting it from proteasomal degradation and promotes p53 acetylation at Lys120, which is crucial for apoptosis-related gene expression (Zhuge2016PDCD5; Xu2012PDCD5).

Additionally, PDCD5 forms a complex with Tip60, a histone acetyltransferase involved in DNA damage response. This interaction enhances Tip60's stability and acetyltransferase activity, particularly after UV irradiation, and promotes Tip60-dependent acetylation of p53, facilitating apoptosis (Xu2009PDCD5). These interactions highlight PDCD5's role as a regulatory co-chaperone and a facilitator of apoptosis through its interactions with key proteins involved in cell cycle regulation and stress responses.


## References


[1. (Yao2009Structure–function) Hongwei Yao, Lanjun Xu, Yingang Feng, Dongsheng Liu, Yingyu Chen, and Jinfeng Wang. Structure–function correlation of human programmed cell death 5 protein. Archives of Biochemistry and Biophysics, 486(2):141–149, June 2009. URL: http://dx.doi.org/10.1016/j.abb.2009.03.018, doi:10.1016/j.abb.2009.03.018. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2009.03.018)

[2. (Ma2005Two) Xi Ma, Guorui Ruan, Ying Wang, Qiyan Li, Ping Zhu, Ya-Zhen Qin, Jin-Lan Li, Yan-Rong Liu, Dalong Ma, and Hongshan Zhao. Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5′ regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in chinese population. Clinical Cancer Research, 11(24):8592–8599, December 2005. URL: http://dx.doi.org/10.1158/1078-0432.ccr-05-0039, doi:10.1158/1078-0432.ccr-05-0039. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-05-0039)

[3. (Li2016Cellular) Ge Li, Dalong Ma, and Yingyu Chen. Cellular functions of programmed cell death 5. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863(4):572–580, April 2016. URL: http://dx.doi.org/10.1016/j.bbamcr.2015.12.021, doi:10.1016/j.bbamcr.2015.12.021. This article has 35 citations.](https://doi.org/10.1016/j.bbamcr.2015.12.021)

[4. (Tracy2014Programmed) Christopher M. Tracy, Amy J. Gray, Jorge Cuéllar, Tanner S. Shaw, Alyson C. Howlett, Ryan M. Taylor, John T. Prince, Natalie G. Ahn, José M. Valpuesta, and Barry M. Willardson. Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (cct) to regulate β-tubulin folding. Journal of Biological Chemistry, 289(7):4490–4502, February 2014. URL: http://dx.doi.org/10.1074/jbc.m113.542159, doi:10.1074/jbc.m113.542159. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m113.542159)

[5. (Liu2004Human) Dongsheng Liu, Yingang Feng, Yuan Cheng, and Jinfeng Wang. Human programmed cell death 5 protein has a helical-core and two dissociated structural regions. Biochemical and Biophysical Research Communications, 318(2):391–396, May 2004. URL: http://dx.doi.org/10.1016/j.bbrc.2004.04.044, doi:10.1016/j.bbrc.2004.04.044. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2004.04.044)

[6. (Xu2012PDCD5) Lanjun Xu, Jing Hu, Yuanbo Zhao, Jia Hu, Juan Xiao, Yanming Wang, Dalong Ma, and Yingyu Chen. Pdcd5 interacts with p53 and functions as a positive regulator in the p53 pathway. Apoptosis, 17(11):1235–1245, August 2012. URL: http://dx.doi.org/10.1007/s10495-012-0754-x, doi:10.1007/s10495-012-0754-x. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10495-012-0754-x)

[7. (Liu2005The) Dongsheng Liu, Hongwei Yao, Yaoyao Chen, Yingang Feng, Yingyu Chen, and Jinfeng Wang. The n-terminal 26-residue fragment of human programmed cell death 5 protein can form a stable α-helix having unique electrostatic potential character. Biochemical Journal, 392(1):47–54, November 2005. URL: http://dx.doi.org/10.1042/bj20050688, doi:10.1042/bj20050688. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20050688)

[8. (Zhuge2016PDCD5) Changjing Zhuge, Xiaojuan Sun, Yingyu Chen, and Jinzhi Lei. Pdcd5 functions as a regulator of p53 dynamics in the dna damage response. Journal of Theoretical Biology, 388:1–10, January 2016. URL: http://dx.doi.org/10.1016/j.jtbi.2015.09.025, doi:10.1016/j.jtbi.2015.09.025. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jtbi.2015.09.025)

[9. (Spinola2006Association) Monica Spinola, Peter Meyer, Stefan Kammerer, F. Stefania Falvella, Melanie B. Boettger, Carolyn R. Hoyal, Carmen Pignatiello, Reiner Fischer, Richard B. Roth, Ugo Pastorino, Karl Haeussinger, Matthew R. Nelson, Rainer Dierkesmann, Tommaso A. Dragani, and Andreas Braun. Association of the pdcd5 locus with lung cancer risk and prognosis in smokers. Journal of Clinical Oncology, 24(11):1672–1678, April 2006. URL: http://dx.doi.org/10.1200/jco.2005.04.4339, doi:10.1200/jco.2005.04.4339. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1200/jco.2005.04.4339)

[10. (Xu2009PDCD5) Lanjun Xu, Yingyu Chen, Quansheng Song, Dong Xu, Ying Wang, and Dalong Ma. Pdcd5 interacts with tip60 and functions as a cooperator in acetyltransferase activity and dna damage-induced apoptosis. Neoplasia, 11(4):345-IN2, April 2009. URL: http://dx.doi.org/10.1593/neo.81524, doi:10.1593/neo.81524. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1593/neo.81524)